These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7243776)

  • 1. The effect of heparin-free dialysis on abnormal lipid metabolism in patients on regular dialysis treatment.
    Matsui N; Nakamura Y; Shinoda T; Iwamoto H; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
    Proc Eur Dial Transplant Assoc; 1980; 17():253-8. PubMed ID: 7243776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of heparin in the changes of lipid patterns during a single hemodialysis.
    Teraoka J; Matsui N; Nakagawa S; Takeuchi J
    Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
    Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
    ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
    Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T
    Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of unfavourable effects of heparin with use of gabexate mesilate in dialysis.
    Matsui N; Nakagawa S; Sasaoka T; Suenaga M; Yoshiyama N; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1979; 16():135-40. PubMed ID: 121458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-tern effect of hemodialysis without heparin on abnormal lipid metabolism in patients on regular dialysis treatment (author's transl)].
    Matsui N; Shinoda T; Akiba T; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1225-32. PubMed ID: 7328898
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
    Kronenberg F; König P; Lhotta K; Steinmetz A; Dieplinger H
    Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
    Mo JK; Li YX; Lei D; Wu DH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin (LMWH): influence on blood lipids in patients on chronic haemodialysis.
    Schmitt Y; Schneider H
    Nephrol Dial Transplant; 1993; 8(5):438-42. PubMed ID: 8393549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of heparin on lipid metabolism in patients with chronic renal failure treated with hemodialysis].
    Chmielewska J; Poplawski A
    Pol Tyg Lek; 1977 Aug; 32(34):1337-40. PubMed ID: 905179
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia.
    Gillett MP; Obineche EN; El-Rokhaimi M; Lakhani MS; Abdulle A; Sulaiman M
    J Nephrol; 2001; 14(6):472-80. PubMed ID: 11783603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of heparin on lipid metabolism in acute experimental pancreatitis (AEP).
    Kinalska I; Gabryelewicz A
    Z Exp Chir; 1980; 13(4):191-6. PubMed ID: 7415342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-blocker therapy on serum lipoprotein profiles in patients on renal dialysis and in diabetic nephropathy.
    Kontessis PS; Jayathissa SA; Walker JD; Mattock MB; Williams DG; Viberti GC
    Diabetes Res; 1993; 23(3):93-104. PubMed ID: 7712687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids, blood pressure and bone metabolism after growth hormone therapy in elderly hemodialysis patients.
    Viidas U; Johannsson G; Mattson-Hultén L; Ahlmén J
    J Nephrol; 2003; 16(2):231-7. PubMed ID: 12768070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.